Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
HONG KONG (Reuters) - Breast cancer cells can shut down a powerful immune response in the body, which allows the disease to spread to the patient's bones, researchers in Australia reported on Monday.
NEW YORK (Reuters Health) - Women who were in the workforce before a breast cancer diagnosis often get back to their normal job routine after treatment, a study of Swedish women finds.
(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved Novartis AG's drug Afinitor to treat women with a certain type of breast cancer.
Young age--under 40 years old--when diagnosed with breast cancer does not by itself predict a worse outcome.
NEW YORK (Reuters Health) - Women under 40 who use estrogen to ease menopause symptoms after having their ovaries removed do not have an increased risk of breast cancer, according to a new study.
NEW YORK (Reuters Health) - A new study is fueling hopes that metformin, a cheap and relatively safe diabetes drug, might have cancer-fighting properties.
CHICAGO (Reuters) - Not too long ago, knowing the organ where a cancer first takes hold was generally all a doctor needed to determine what treatments to use. Not anymore.
Advances in understanding cancer at the molecular level mean doctors can better select the drugs that will most help individual patients. To do so, they must identify which genetic mutations are driving the growth of a patient's tumor, and that shift is making their work much harder.
CHICAGO (Reuters) - Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try breakthrough drugs while they have the best shot at a cure.
CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs.
(Reuters) - A pair of newer drugs proved no better, and by some measures inferior, to the older and cheaper chemotherapy agent paclitaxel in patients with locally advanced or metastatic breast cancer, according to results of a late stage study.